Clinzadin CM Softgel contains Clindamycin 100 mg, Metronidazole 5 mg, and Clotrimazole 200 mg, a broad-spectrum gynecological anti-infective combination formulated for the treatment of mixed vaginal infections.
Clindamycin provides effective antibacterial activity against anaerobic organisms, Metronidazole targets protozoal and anaerobic bacterial infections, while Clotrimazole offers potent antifungal action against Candida species. Together, this combination ensures comprehensive coverage of common vaginal pathogens.
Clinically, Clinzadin CM Softgel is indicated for bacterial vaginosis, trichomoniasis, vulvovaginal candidiasis, and mixed vaginal infections, helping relieve abnormal discharge, itching, irritation, and discomfort while restoring healthy vaginal flora.
The softgel formulation allows targeted local action, improved retention, and better patient compliance, making it a preferred choice in gynecology clinics, hospitals, and women’s health practices with consistent therapeutic demand.